CN109619089A - 一种胰岛细胞低温保存液及其使用方法 - Google Patents
一种胰岛细胞低温保存液及其使用方法 Download PDFInfo
- Publication number
- CN109619089A CN109619089A CN201811610661.0A CN201811610661A CN109619089A CN 109619089 A CN109619089 A CN 109619089A CN 201811610661 A CN201811610661 A CN 201811610661A CN 109619089 A CN109619089 A CN 109619089A
- Authority
- CN
- China
- Prior art keywords
- islet cells
- cryopreservation solution
- cell
- stem cell
- mescenchymal stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005138 cryopreservation Methods 0.000 title claims abstract description 91
- 210000004153 islets of langerhan Anatomy 0.000 title claims abstract description 60
- 238000000034 method Methods 0.000 title claims abstract description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 210000000130 stem cell Anatomy 0.000 claims abstract description 27
- 239000003636 conditioned culture medium Substances 0.000 claims abstract description 23
- 239000002609 medium Substances 0.000 claims abstract description 16
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 12
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 12
- 150000001335 aliphatic alkanes Chemical class 0.000 claims abstract description 12
- 239000003086 colorant Substances 0.000 claims abstract description 12
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 claims abstract description 11
- GDXWHFPKFUYWBE-UHFFFAOYSA-N [F].Cl Chemical compound [F].Cl GDXWHFPKFUYWBE-UHFFFAOYSA-N 0.000 claims abstract description 10
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims abstract description 9
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 claims abstract description 9
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims description 50
- 241000282898 Sus scrofa Species 0.000 claims description 16
- 239000001963 growth medium Substances 0.000 claims description 16
- 210000002966 serum Anatomy 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 230000001640 apoptogenic effect Effects 0.000 claims description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
- 235000018417 cysteine Nutrition 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- 230000001464 adherent effect Effects 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 230000001681 protective effect Effects 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 2
- 230000007910 cell fusion Effects 0.000 claims 1
- 230000029142 excretion Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000011177 media preparation Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 44
- 238000011084 recovery Methods 0.000 description 19
- 238000004321 preservation Methods 0.000 description 14
- 210000000496 pancreas Anatomy 0.000 description 11
- 230000032258 transport Effects 0.000 description 11
- 230000004899 motility Effects 0.000 description 8
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 4
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000001427 coherent effect Effects 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940089468 hydroxyethylpiperazine ethane sulfonic acid Drugs 0.000 description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- -1 apoptotic body etc. Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001342 constant potential amperometry Methods 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000037890 multiple organ injury Diseases 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000002689 xenotransplantation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811610661.0A CN109619089B (zh) | 2018-12-27 | 2018-12-27 | 一种胰岛细胞低温保存液及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811610661.0A CN109619089B (zh) | 2018-12-27 | 2018-12-27 | 一种胰岛细胞低温保存液及其使用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109619089A true CN109619089A (zh) | 2019-04-16 |
CN109619089B CN109619089B (zh) | 2020-04-21 |
Family
ID=66078312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811610661.0A Active CN109619089B (zh) | 2018-12-27 | 2018-12-27 | 一种胰岛细胞低温保存液及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109619089B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110367242A (zh) * | 2019-08-02 | 2019-10-25 | 陕西佰傲干细胞再生医学有限公司 | 凋亡小体保存液及凋亡小体的保存方法 |
CN112251397A (zh) * | 2020-10-30 | 2021-01-22 | 湖南赛诺生物科技股份有限公司 | 一种新生猪胰岛细胞培养方法 |
CN112715533A (zh) * | 2021-02-26 | 2021-04-30 | 康妍葆(北京)干细胞科技有限公司 | 一种间充质干细胞的冻存液及冻存方法 |
CN114831107A (zh) * | 2022-04-11 | 2022-08-02 | 依科赛生物科技(太仓)有限公司 | 一种细胞和组织低温保存液及其配制方法、应用 |
CN114868736A (zh) * | 2022-03-08 | 2022-08-09 | 四川中科奥格生物科技有限公司 | 一种胰岛细胞稳定液及其制备方法和用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102197802A (zh) * | 2011-03-25 | 2011-09-28 | 中国人民解放军南京军区福州总医院 | 一种胰岛冻存保护剂及其使用方法 |
CN105850979A (zh) * | 2016-03-14 | 2016-08-17 | 广州赛莱拉干细胞科技股份有限公司 | 一种骨髓间充质干细胞的冻存保护液及冻存方法 |
CN106982822A (zh) * | 2017-05-24 | 2017-07-28 | 湖南赛诺生物科技股份有限公司 | 一种猪胰岛细胞冻存液及冻存方法 |
-
2018
- 2018-12-27 CN CN201811610661.0A patent/CN109619089B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102197802A (zh) * | 2011-03-25 | 2011-09-28 | 中国人民解放军南京军区福州总医院 | 一种胰岛冻存保护剂及其使用方法 |
CN105850979A (zh) * | 2016-03-14 | 2016-08-17 | 广州赛莱拉干细胞科技股份有限公司 | 一种骨髓间充质干细胞的冻存保护液及冻存方法 |
CN106982822A (zh) * | 2017-05-24 | 2017-07-28 | 湖南赛诺生物科技股份有限公司 | 一种猪胰岛细胞冻存液及冻存方法 |
Non-Patent Citations (2)
Title |
---|
HARDIKAR, AA等: ""Islet cryopreservation: Improved recovery following taurine pretreatment"", 《CELL TRANSPLANTATION》 * |
K. OMORI等: ""Improvement of Human Islet Cryopreservation by a p38 MAPK Inhibito"", 《AMERICAN JOURNAL OF TRANSPLANTATION》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110367242A (zh) * | 2019-08-02 | 2019-10-25 | 陕西佰傲干细胞再生医学有限公司 | 凋亡小体保存液及凋亡小体的保存方法 |
CN112251397A (zh) * | 2020-10-30 | 2021-01-22 | 湖南赛诺生物科技股份有限公司 | 一种新生猪胰岛细胞培养方法 |
CN112251397B (zh) * | 2020-10-30 | 2022-02-15 | 湖南赛诺生物科技股份有限公司 | 一种新生猪胰岛细胞培养方法 |
CN112715533A (zh) * | 2021-02-26 | 2021-04-30 | 康妍葆(北京)干细胞科技有限公司 | 一种间充质干细胞的冻存液及冻存方法 |
CN112715533B (zh) * | 2021-02-26 | 2022-04-29 | 康妍葆(北京)干细胞科技有限公司 | 一种间充质干细胞的冻存液及冻存方法 |
CN114868736A (zh) * | 2022-03-08 | 2022-08-09 | 四川中科奥格生物科技有限公司 | 一种胰岛细胞稳定液及其制备方法和用途 |
CN114868736B (zh) * | 2022-03-08 | 2022-12-09 | 四川中科奥格生物科技有限公司 | 一种胰岛细胞稳定液及其制备方法和用途 |
CN114831107A (zh) * | 2022-04-11 | 2022-08-02 | 依科赛生物科技(太仓)有限公司 | 一种细胞和组织低温保存液及其配制方法、应用 |
CN114831107B (zh) * | 2022-04-11 | 2023-02-24 | 苏州依科赛生物科技股份有限公司 | 一种细胞和组织低温保存液及其配制方法、应用 |
Also Published As
Publication number | Publication date |
---|---|
CN109619089B (zh) | 2020-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109619089A (zh) | 一种胰岛细胞低温保存液及其使用方法 | |
US5679565A (en) | Method of preserving pancreatic islets | |
Zhang et al. | Emerging technologies in medical applications of minimum volume vitrification | |
JP2008528034A (ja) | 直ぐに利用可能な臍帯血から誘導される細胞物質、及びその組成物の提供方法 | |
CN102036555A (zh) | 移植物存储 | |
Paynter | Principles and practical issues for cryopreservation of nerve cells | |
Huang et al. | Advanced technologies for the preservation of mammalian biospecimens | |
CN109892319B (zh) | 一种用于猪胰岛细胞的冻存复苏方法及冻存液和复苏液 | |
Vadivelu et al. | Cryoprotectant-free freezing of cells using liquid marbles filled with hydrogel | |
Yakhnenko et al. | Cryopreservation of Human Insulin Expressing Cells Macro-Encapsulated in a Durable Therapeutic Immunoisolating Device Theracyte™ | |
CN106520679B (zh) | 一种用于培养胰腺干细胞的试剂盒 | |
Smith et al. | Human umbilical cord mesenchymal stromal cell isolation, expansion, cryopreservation, and characterization | |
CN114557337A (zh) | 脐带间充质干细胞无蛋白非程序冻存液及其制备方法 | |
CN111838139A (zh) | 一种无蛋白细胞冻存液及其应用 | |
KR20210045443A (ko) | 아카보즈 또는 스타키오스를 포함하는 포유동물 세포 보존용 액 | |
CN109486766A (zh) | 一种泪腺干细胞、泪腺干细胞的培养体系和培养方法 | |
US20060193838A1 (en) | Method and composition for treating diabetes | |
CN112450206A (zh) | 一种直接静脉使用的非程序细胞冻存液 | |
US9005886B2 (en) | Method for cryopreservation of human spermatozoa free from seminal plasma using a fast and simple aseptic vitrification-devitrification process; portable kit for carrying out the method; and use of the same for treatment of disorders related to reproductive failures | |
CN108293980B (zh) | 一种神经干细胞球玻璃化冻存/复苏方法 | |
CN109097327A (zh) | 一种干细胞培养基及干细胞分离方法 | |
Lloyd et al. | Development of a protocol for cryopreservation of hepatocytes for use in bioartificial liver systems | |
CN108902130B (zh) | 一种神经干细胞球玻璃化冻存/复苏方法及冻存装置 | |
CN106962323A (zh) | 非人灵长类动物的精子冷冻保存及复苏方法 | |
Farooque et al. | Protocol development for vitrification of tissue-engineered cartilage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A cryopreservation solution for islet cells and its application method Effective date of registration: 20201229 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2020980010070 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230105 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2020980010070 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A cryopreservation solution for islet cells and its use method Effective date of registration: 20230112 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980031055 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231124 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980031055 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A low-temperature preservation solution for pancreatic islet cells and its usage method Effective date of registration: 20231129 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980068297 |